Clinuvel Pharmaceuticals Ltd (CLVLF) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
17/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseCLVLF / S&P -27.81% / 15.20% |
LoseCLVLF / S&P CLVLF unavailable / 15.00% |
LoseCLVLF / S&P CLVLF unavailable / 50.40% |
| 2026-Q11/3 |
WinCLVLF / S&P 9.74% / -4.33% |
LoseCLVLF / S&P CLVLF unavailable / 11.30% |
LoseCLVLF / S&P CLVLF unavailable / 27.70% |
| 2025-Q40/3 |
LoseCLVLF / S&P -2.53% / 2.65% |
LoseCLVLF / S&P CLVLF unavailable / 9.00% |
LoseCLVLF / S&P CLVLF unavailable / 13.40% |
| 2025-Q31/3 |
WinCLVLF / S&P 9.42% / 8.12% |
LoseCLVLF / S&P CLVLF unavailable / 4.61% |
LoseCLVLF / S&P CLVLF unavailable / 13.45% |
| 2025-Q20/3 |
LoseCLVLF / S&P -3.09% / 10.94% |
LoseCLVLF / S&P CLVLF unavailable / 4.83% |
LoseCLVLF / S&P CLVLF unavailable / 10.63% |
| 2025-Q10/3 |
LoseCLVLF / S&P -11.83% / -4.27% |
LoseCLVLF / S&P CLVLF unavailable / 4.98% |
LoseCLVLF / S&P CLVLF unavailable / 10.57% |
| 2024-Q40/3 |
LoseCLVLF / S&P -8.94% / 2.41% |
LoseCLVLF / S&P CLVLF unavailable / 5.25% |
LoseCLVLF / S&P CLVLF unavailable / 6.15% |
| 2024-Q30/3 |
LoseCLVLF / S&P -7.73% / 5.89% |
LoseCLVLF / S&P CLVLF unavailable / 5.89% |
LoseCLVLF / S&P CLVLF unavailable / 6.11% |
| 2024-Q21/3 |
WinCLVLF / S&P 15.03% / 4.28% |
LoseCLVLF / S&P CLVLF unavailable / 5.38% |
LoseCLVLF / S&P CLVLF unavailable / 5.12% |
| 2024-Q10/3 |
LoseCLVLF / S&P -16.54% / 10.56% |
LoseCLVLF / S&P CLVLF unavailable / 5.71% |
LoseCLVLF / S&P CLVLF unavailable / 5.59% |
| 2023-Q40/3 |
LoseCLVLF / S&P 8.68% / 11.69% |
LoseCLVLF / S&P CLVLF unavailable / 6.81% |
LoseCLVLF / S&P CLVLF unavailable / 7.78% |
| 2023-Q30/3 |
LoseCLVLF / S&P -19.04% / -3.27% |
LoseCLVLF / S&P CLVLF unavailable / 7.52% |
LoseCLVLF / S&P CLVLF unavailable / -5.03% |
| 2023-Q20/3 |
LoseCLVLF / S&P -3.23% / 8.74% |
LoseCLVLF / S&P CLVLF unavailable / 9.50% |
LoseCLVLF / S&P CLVLF unavailable / -8.57% |
| 2023-Q10/3 |
LoseCLVLF / S&P -11.17% / 7.50% |
LoseCLVLF / S&P CLVLF unavailable / 10.77% |
LoseCLVLF / S&P CLVLF unavailable / -15.69% |
| 2022-Q41/3 |
WinCLVLF / S&P 21.39% / 7.56% |
LoseCLVLF / S&P CLVLF unavailable / 11.88% |
LoseCLVLF / S&P CLVLF unavailable / -17.99% |
| 2022-Q31/3 |
WinCLVLF / S&P 18.31% / -4.88% |
LoseCLVLF / S&P CLVLF unavailable / 13.47% |
LoseCLVLF / S&P CLVLF unavailable / -1.41% |
| 2022-Q20/3 |
LoseCLVLF / S&P -32.29% / -16.10% |
LoseCLVLF / S&P CLVLF unavailable / 13.71% |
LoseCLVLF / S&P CLVLF unavailable / 11.04% |
| 2022-Q10/3 |
LoseCLVLF / S&P -29.20% / -4.60% |
LoseCLVLF / S&P CLVLF unavailable / 15.97% |
LoseCLVLF / S&P CLVLF unavailable / 42.23% |
| 2021-Q40/3 |
LoseCLVLF / S&P -34.17% / 11.03% |
LoseCLVLF / S&P CLVLF unavailable / 15.00% |
LoseCLVLF / S&P CLVLF unavailable / 96.40% |
| 2021-Q31/3 |
WinCLVLF / S&P 43.95% / 0.58% |
LoseCLVLF / S&P CLVLF unavailable / 10.77% |
LoseCLVLF / S&P CLVLF unavailable / 69.42% |
| 2021-Q20/3 |
LoseCLVLF / S&P 1.32% / 8.55% |
LoseCLVLF / S&P CLVLF unavailable / 6.58% |
LoseCLVLF / S&P CLVLF unavailable / 51.81% |
| 2021-Q11/3 |
WinCLVLF / S&P 23.83% / 6.17% |
LoseCLVLF / S&P CLVLF unavailable / -1.06% |
LoseCLVLF / S&P CLVLF unavailable / 7.39% |
| 2020-Q40/3 |
LoseCLVLF / S&P 3.63% / 12.15% |
LoseCLVLF / S&P CLVLF unavailable / -3.72% |
LoseCLVLF / S&P CLVLF unavailable / -33.42% |
| 2020-Q30/3 |
LoseCLVLF / S&P -3.34% / 8.93% |
LoseCLVLF / S&P CLVLF unavailable / -2.04% |
LoseCLVLF / S&P CLVLF unavailable / -27.10% |
| 2020-Q21/3 |
WinCLVLF / S&P 52.50% / 20.54% |
LoseCLVLF / S&P CLVLF unavailable / -0.46% |
LoseCLVLF / S&P CLVLF unavailable / -27.11% |
| 2020-Q10/3 |
LoseCLVLF / S&P -45.11% / -19.60% |
LoseCLVLF / S&P CLVLF unavailable / 3.47% |
LoseCLVLF / S&P CLVLF unavailable / -14.75% |
| 2019-Q41/3 |
WinCLVLF / S&P 15.15% / 9.07% |
LoseCLVLF / S&P CLVLF unavailable / 5.36% |
LoseCLVLF / S&P CLVLF unavailable / 2.99% |
| 2019-Q30/3 |
LoseCLVLF / S&P -24.94% / 1.70% |
LoseCLVLF / S&P CLVLF unavailable / 5.02% |
LoseCLVLF / S&P CLVLF unavailable / 0.21% |
| 2019-Q21/3 |
WinCLVLF / S&P 33.28% / 4.30% |
LoseCLVLF / S&P CLVLF unavailable / 6.64% |
LoseCLVLF / S&P CLVLF unavailable / 8.65% |
| 2019-Q11/3 |
WinCLVLF / S&P 40.95% / 13.65% |
LoseCLVLF / S&P CLVLF unavailable / 8.12% |
LoseCLVLF / S&P CLVLF unavailable / 14.29% |
| 2018-Q40/3 |
LoseCLVLF / S&P -20.25% / -13.52% |
LoseCLVLF / S&P CLVLF unavailable / 9.05% |
LoseCLVLF / S&P CLVLF unavailable / 18.23% |
| 2018-Q31/3 |
WinCLVLF / S&P 91.73% / 7.71% |
LoseCLVLF / S&P CLVLF unavailable / 10.21% |
LoseCLVLF / S&P CLVLF unavailable / 19.06% |
| 2018-Q21/3 |
WinCLVLF / S&P 6.04% / 3.43% |
LoseCLVLF / S&P CLVLF unavailable / 9.03% |
LoseCLVLF / S&P CLVLF unavailable / 14.46% |
| 2018-Q11/3 |
WinCLVLF / S&P 24.48% / -0.76% |
LoseCLVLF / S&P CLVLF unavailable / 7.68% |
LoseCLVLF / S&P CLVLF unavailable / 12.46% |
| 2017-Q41/3 |
WinCLVLF / S&P 15.74% / 6.64% |
LoseCLVLF / S&P CLVLF unavailable / 7.03% |
LoseCLVLF / S&P CLVLF unavailable / 13.82% |
| 2017-Q30/3 |
LoseCLVLF / S&P 1.69% / 4.48% |
LoseCLVLF / S&P CLVLF unavailable / 5.68% |
LoseCLVLF / S&P CLVLF unavailable / 17.57% |
| 2017-Q20/3 |
LoseCLVLF / S&P -2.03% / 3.09% |
LoseCLVLF / S&P CLVLF unavailable / 4.83% |
LoseCLVLF / S&P CLVLF unavailable / 17.74% |
| 2017-Q10/3 |
LoseCLVLF / S&P 2.26% / 6.07% |
LoseCLVLF / S&P CLVLF unavailable / 3.67% |
LoseCLVLF / S&P CLVLF unavailable / 13.32% |
| 2016-Q41/3 |
WinCLVLF / S&P 13.25% / 3.82% |
LoseCLVLF / S&P CLVLF unavailable / 2.09% |
LoseCLVLF / S&P CLVLF unavailable / 7.05% |
| 2016-Q31/3 |
WinCLVLF / S&P 57.05% / 3.85% |
LoseCLVLF / S&P CLVLF unavailable / 0.20% |
LoseCLVLF / S&P CLVLF unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CLVLF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -10.59% | 20.78% |
| Annualized return | -10.59% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CLVLF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -70.64% | 83.14% |
| Annualized return | -21.74% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | CLVLF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 93.33% | 319.30% |
| Annualized return | 6.81% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.